Illumina countersues Qiagen in patent fight; Sleep apnea device field could surpass $19B by 2017;

 @FierceMedDev: Philips Healthcare grows solidly during Q2. More | Follow @FierceMedDev

 @MarkHFierce: In a novel twist for NIH funding, a $65M grant is designed to boost translational device/Dx research. Item | Follow @MarkHFierce

 @DamianFierce: Navidea is moving forward in the Alzheimer's imaging race, vying with GE Healthcare and Eli Lilly. Story | Follow @DamianFierce

> San Diego diagnostics company Illumina ($ILMN) is countersuing Intelligent Bio-Systems and Qiagen (which recently acquired IBS) for infringement of three Illumina DNA-sequencing patents. Columbia University and IBS initially sued Illumina for patent infringement on March 26. Release

> Aurora Imaging Technology inked an exclusive China distribution deal with Sumec Group, drastically boosting Aurora's reach in the Chinese market for its breast MRI technology. Release

> BG Medicine has filed a 510(k) application for a new test designed to measure the blood level of galectin-3, a protein that plays a role in worsening heart failure. Release

> Bollington, a U.K. insurance broker, will expand into the medical devices sector. Story

> Life Technologies ($LIFE) has developed a same-day molecular diagnostic for E. coli, and the company is working with the USDA to implement the test. More

> Some market analysts predict the global sleep apnea device field to be worth $19.7 billion by 2017. Story

> Phoenix's InnerSpace Neuro has launched a new tunneled ventricular catheter, designed to treat traumatic brain injury. Item

Biotech News

 @FierceBiotech: PTC investors back lead orphan drug with $30M round. More | Follow @FierceBiotech

 @JohnCFierce: PR folks in Texas taking exception with my remark about CPRIT controversies in cell medica piece. Just the one, they say. (ha, ha, ha) | Follow @JohnCFierce

 @RyanMFierce: Venter and Stanford built first complete software model of organism, a simple bacterium. Simulated humans someday? More | Follow @RyanMFierce

> Biotech execs get creative as venture cash flow dwindles. More

> Cell Medica lands $26.5M in venture cash to fuel U.S. expansion. News

Pharma News

 @FiercePharma: Indian companies often plant moles to spy on competitors and hire hackers to dig into IT systems, survey finds. More | Follow @FiercePharma

> J&J appeals $1.2B Risperdal marketing fine. More

> Onyx staffs up for Kyprolis' assault on myeloma market. Story

> Afinitor's breast cancer OK could add $1.5B to Novartis sales. News

CRO News

> DSM expands CMO biz with first Brazilian deal. Story

> Indian PM urged to tax CMOs in excise-free zones. Article

> Parexel partners to develop drugs in S. Korea. News

> CoreRx triples capacity with Florida plant. Item

> Covance selling off animal testing lab. Article

Biotech IT News

> 10 Reasons Why Biotech Needs Big Data. Special Report

> Pfizer builds credentials as 'data company'. More

> Medidata CEO seeks organic growth over big eClinical buyouts. Item

> WorldOne takes over Sermo social network for docs. News

> NCI spotlights cancer gene-drug matchmaker software. Story

> Venter, Stanford build first computer model of complete organism. Article

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.